Ellingson Rachel has filed 17 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 8170 shares of BIOLIFE SOLUTIONS INC ($BLFS) on February 24, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | BIOLIFE SOLUTIONS INC | $BLFS | Ellingson Rachel | Director | A | Common Stock | 8170 | $0.00 | 57,995.0000 | 48,723,535 | 16.40% | 0.02% |
| March 18, 2025 | BIOLIFE SOLUTIONS INC | $BLFS | Ellingson Rachel | Director | A | Common Stock | 6876 | $0.00 | 49,825.0000 | 46,067,073 | 16.01% | 0.01% |
| Feb. 20, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | M | Restricted Stock Units | 1566 | $0.00 | 3,131.0000 | 317,500,000 | 33.34% | 0.00% |
| Feb. 20, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | M | Common Stock | 1566 | $0.00 | 12,397.0000 | 317,500,000 | 14.46% | 0.00% |
| Feb. 20, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | F | Common Stock | 491 | $103.46 | 11,906.0000 | 317,500,000 | 3.96% | 0.00% |
| Feb. 14, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | A | Restricted Stock Units | 5572 | $0.00 | 5,572.0000 | 317,500,000 | 9999.99% | 0.00% |
| Feb. 18, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | M | Restricted Stock Units | 5572 | $0.00 | 0.0000 | 317,500,000 | 100.00% | 0.00% |
| Feb. 18, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | F | Common Stock | 1792 | $101.00 | 10,831.0000 | 317,500,000 | 14.20% | 0.00% |
| Feb. 18, 2025 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | Chief Administrative Officer | M | Common Stock | 5572 | $0.00 | 12,623.0000 | 317,500,000 | 79.02% | 0.00% |
| March 8, 2024 | BIOLIFE SOLUTIONS INC | $BLFS | Ellingson Rachel | Director | A | Common Stock | 11264 | $0.00 | 42,949.0000 | 43,719,185 | 35.55% | 0.03% |
| March 6, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | M | Restricted Stock Units | 1419 | $0.00 | 2,837.0000 | 316,200,000 | 33.34% | 0.00% |
| March 6, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | M | Common Stock | 1419 | $0.00 | 7,291.0000 | 316,200,000 | 24.17% | 0.00% |
| March 6, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | F | Common Stock | 445 | $125.82 | 6,846.0000 | 316,200,000 | 6.10% | 0.00% |
| Feb. 25, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | M | Common Stock | 1762 | $0.00 | 6,460.0000 | 316,200,000 | 37.51% | 0.00% |
| Feb. 25, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | F | Common Stock | 588 | $128.80 | 5,872.0000 | 316,200,000 | 9.10% | 0.00% |
| Feb. 25, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | M | Restricted Stock Units | 1762 | $0.00 | 0.0000 | 316,200,000 | 100.00% | 0.00% |
| Feb. 20, 2024 | ZIMMER BIOMET HOLDINGS, INC. | $ZBH | Ellingson Rachel | SVP & Chief Strategy Officer | A | Restricted Stock Units | 4697 | $0.00 | 4,697.0000 | 316,200,000 | 9999.99% | 0.00% |